Stapgen Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Latest Deal Amount
  • $25M

  • Investors
  • 1

Stapgen General Information

Description

Developer of gut health technology designed to prevent chronic inflammatory diseases such as neurodegenerative diseases, diabetes, cardiovascular diseases, Gastrointestinal disorders, and periodontal disease. The company offers diagnostic tests to measure intestinal alkaline phosphatase levels in stool samples for the early detection of type two diabetes, therapeutic supplements for disease prevention, and specialized mouthwash containing intestinal alkaline phosphatase to prevent oral diseases, enabling individuals at risk of metabolic and neurodegenerative conditions to achieve health outcomes.

Contact Information

Website
www.stapgen.com
Ownership Status
Privately Held (no backing)
Financing Status
Pending Transaction (VC)
Corporate Office
  • 492 Summer Avenue
  • Reading, MA 01867
  • United States
+1 (978)
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Corporate Office
  • 492 Summer Avenue
  • Reading, MA 01867
  • United States
+1 (978)

Stapgen Timeline

20232024202520262027
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stapgen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 31-Mar-2027 $25M Upcoming Pre-Clinical Trials
3. Accelerator/Incubator 05-Dec-2024 Completed Pre-Clinical Trials
2. Equity Crowdfunding 01-Mar-2023 $62.7K $78.2K Completed Pre-Clinical Trials
1. Capitalization 20-Oct-2022 $15.5K $15.5K Completed Pre-Clinical Trials
To view Stapgen’s complete valuation and funding history, request access »

Stapgen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stapgen Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bioincubator Accelerator/Incubator
To view Stapgen’s complete investors history, request access »

Stapgen FAQs

  • When was Stapgen founded?

    Stapgen was founded in 2022.

  • Where is Stapgen headquartered?

    Stapgen is headquartered in Reading, MA.

  • What is the size of Stapgen?

    Stapgen has 2 total employees.

  • What industry is Stapgen in?

    Stapgen’s primary industry is Diagnostic Equipment.

  • Is Stapgen a private or public company?

    Stapgen is a Private company.

  • What is Stapgen’s current revenue?

    The current revenue for Stapgen is .

  • How much funding has Stapgen raised over time?

    Stapgen has raised $78.2K.

  • Who are Stapgen’s investors?

    Bioincubator has invested in Stapgen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process